Jose Luis Martinez, MD
About Jose Luis Martinez, MD
Jose Luis Martinez, MD, serves as the Medical Director of Clinical Development for Oncology Therapeutics at BridgeBio. He has extensive experience in oncology and clinical development, having held senior roles at various pharmaceutical companies and a strong educational background in medicine and biology.
Current Role at BridgeBio
Jose Luis Martinez serves as the Medical Director for Clinical Development in Oncology Therapeutics at BridgeBio since 2023. In this role, he is responsible for overseeing clinical development strategies and ensuring alignment with project objectives as outlined in the Clinical Development Plan (CDP). His expertise contributes to advancing oncology therapeutics within the organization.
Previous Experience in Oncology Clinical Development
Prior to his current position, Jose Luis Martinez held several senior roles in oncology clinical development. He worked as the Senior Medical Director for Oncology Medical Affairs at Worldwide Clinical Trials for 7 months in 2021. He also served as Executive Medical Director at Ascentage Pharma from 2021 to 2022, and as Senior Medical Director at MEI Pharma, Inc. from 2015 to 2016. His experience includes direct management and leadership of clinical teams.
Educational Background and Qualifications
Jose Luis Martinez obtained his Medical Doctor degree from Universidad Michoacana de San Nicolás de Hidalgo, where he studied Medicine from 1976 to 1981. He also completed a Clinical Service Postgraduate program at Michoacan University and The Mexican Institute of Health, achieving qualifications as a Physician Surgeon and Obstetrician from 1981 to 1983. Additionally, he holds a B.S. in Biology from the same university.
Clinical Development and Regulatory Expertise
Jose Luis Martinez has extensive experience in clinical development and regulatory compliance. He has been involved in the support and collaboration for a Biologics License Application (BLA) and its approval in both the USA and EU. He has implemented global regulatory and safety standards, including FDA and EMA guidelines, and possesses proficiency in drug safety databases such as ARISg and ARGUS.
International Experience in Clinical Research
Jose Luis Martinez has a robust international background in clinical development, having worked across multiple regions including Canada, Europe, Australia, Latin America, and Asia. His experience encompasses specific countries such as Mexico, Brazil, Argentina, China, and South Korea. He is skilled in oncology-specific evaluation criteria like RECIST and iRECIST, enhancing his capability in global clinical research.